BIOIDENT announces first complete lab-on-a-chip system based on printed semiconductor technology

English Version 108.17 Kb

BIOIDENT Technologies Inc., the leading company in the development of printed optoelectronic solutions for life sciences, today announced the industry's first complete, functional lab-on-a-chip system - the PhotonicFlowTM System. The first application of the PhotonicFlowTM System announced today is comprised of a multiwell chip, a handheld device controller and readout software. The PhotonicFlowTM System is based on BIOIDENT's PhotonicLabTM Platform, which combines printed semiconductors with various lab-on-chip technologies. With this breakthrough technology development, BIOIDENT's customers and partners now have the ability to develop disposable lab-on-a-chip solutions that eliminate the need for expensive and bulky readout systems, enabling cost-effective mobile diagnostics and analysis.

The PhotonicFlowTM System application unveiled today expands upon BIOIDENT's previously announced nanotiter plate prototype amultiwell chip with a fully integrated photodetector array based on printed semiconductor technology with a dedicated pixel under each well on the chip. This array converts light into electrical signals, enabling real-time analysis on multiple agents. The new components of the PhotonicFlowTM System are the handheld device controller for electronic readout of the signals from the photodetector and the readout software for analytics and calibration. This new prototype eliminates the need for large, expensive external readout systems being used today and opens up new opportunities for applications in medical in-vitro diagnostics, chemical/biological threat detection and water testing.

The PhotonicFlowTM System is a significant milestone for BIOIDENT and for the industry, said Dr. Wasiq Bokhari, CEO for BIOIDENT Technologies. This system provides our partners a fast path to deliver new point of care tests that are easy to use and cost effective for end users. By integrating the PhotonicFlowTM System with their existing devices, assays and reagents, our partners can rapidly develop highly sensitive and multiplexed diagnostics across multiple markets. This is truly a next generation mobile lab that is set to transform current diagnostics and analysis testing across multiple markets.

BIOIDENT's PhotonicLabTM Platform uses printed semiconductor based technology to print light detection and electronics capabilities directly onto any surface, including glass and plastic materials, enabling on-chip analysis and diagnostics. In addition, the company uses existing assays and reagents and established testing protocols to deliver real-time and in-situ multi-parameter detection capabilities for all categories of chemical and biological analytes. BIOIDENT's printing process can also be used to create a wide variety of existing in-vitro diagnostic devices, opening up new opportunities and applications for real-time analysis of chemical and biological substances.

The combination of NANOIDENT's SEMICONDUCTOR 2.0TM Platform technology with our highly specialized, market specific testing capabilities has resulted in a new PhotonicFlowTM System that is unique in the market today, said Max Sonnleitner, CTO for BIOIDENT Technologies Inc. We look forward to working with our partners to develop exciting new applications across the health-care, water testing and bio/chem threat detection markets.

Availability
BIOIDENT's PhotonicFlowTM System is available today directly from BIOIDENT for current and future development partners.

For more information about BIOIDENT, the PhotonicFlowTM System and the PhotonicLabTM Platform, please visit http://www.bioident.com.

About BIOIDENT Technologies Inc.
BIOIDENT is the technology leader in the development of printed semiconductor based photonic lab-on-a-chip solutions for the life science market. The company's core technology utilizes the latest breakthroughs in science and nanotechnology to create the PhotonicLabTM Platform. This platform is used to produce the world's first disposable photonic lab-on-a-chip solutions for next generation mobile analytics applications such as in-vitro diagnostics, chemical/biological agent detection, and water/food analysis.

BIOIDENT is a subsidiary of Austria-based NANOIDENT Technologies AG. The company is privately-held with headquarters in Menlo Park, Calif. BIOIDENT leverages NANOIDENT's SEMICONDUCTOR 2.0TM Platform technology and its high-speed manufacturing process, which uses liquid conductive and semi-conductive materials to print electronic circuits on almost any surface using an ink-jet printer. For more information about the company, please visit http://www.bioident.com.